{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:12:15Z","timestamp":1760058735521,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Reports"],"abstract":"<jats:p>Background: Condyloma acuminata (CA) are dysplastic lesions caused by human papillomavirus (HPV) infection. Condylomata acuminata are common in Human Immunodeficiency Virus- (HIV) infected individuals and have been linked to HIV transmission. Current therapeutic options for CA encompass laser, cryotherapy, imiquimod, sinecatechins, podophyllotoxin, and trichloroacetate. These topical therapies have limitations caused by significant local skin reactions, high recurrence rates, prolonged application times, and, in some cases, a supposed lower efficacy in people living with Human Immunodeficiency Virus (PLWH). Previous studies evaluated the effect in the CA treatment of tirbanibulin 1% ointment since it is a synthetic antiproliferative drug approved for the topical treatment of actinic keratoses, acting in two distinct ways: it inhibits microtubule polymerization and Src kinase signaling. Human papilloma virus can up-regulate the kinases Src and Yes, so the tirbanibulin efficient treatment of CA may be due to the suppression of Src kinase signaling. Methods: Here, we present for the first time a retrospective case series of three PLWHIV affected by CA. Case: The patients experienced variable outcomes, with complete resolution of smaller condylomas for 2 out of 3 patients. Adverse events were local and of mild to moderate severity, lasting one week or less. Conclusions: While in need of larger studies, it is possible to hypothesize tirbanibulin 1% ointment as a therapeutic alternative for people living with HIV, especially for condylomas smaller than 1 cm in size.<\/jats:p>","DOI":"10.3390\/idr17030040","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T04:08:24Z","timestamp":1745554104000},"page":"40","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of Condyloma Acuminata with Tirbanibulin 1% Ointment in People Living with HIV: A Case Series with Literature Review"],"prefix":"10.3390","volume":"17","author":[{"given":"Fabio","family":"Artosi","sequence":"first","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terenzio","family":"Cosio","sequence":"additional","affiliation":[{"name":"Department of Laboratory Sciences and Haematological Sciences, Fondazione Policlinico Universitario \u201cA. Gemelli\u201d Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Universit\u00e0 Cattolica Del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Ansaldo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Public Health and Infectious Diseases, Santa Maria Goretti Hospital, Sapienza University of Rome, 00185 Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Cavasio","sequence":"additional","affiliation":[{"name":"Clinical Infectious Diseases, Department of System Medicine, Tor Vergata University, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1452-0333","authenticated-orcid":false,"given":"Loredana","family":"Sarmati","sequence":"additional","affiliation":[{"name":"Clinical Infectious Diseases, Department of System Medicine, Tor Vergata University, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-6896","authenticated-orcid":false,"given":"Luca","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7447-6798","authenticated-orcid":false,"given":"Elena","family":"Campione","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Systems Medicine, University of Rome Tor Vergata, 00133 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"ref_1","first-page":"80","article-title":"Review of HPV-Related Diseases and Cancers","volume":"40","author":"Brianti","year":"2017","journal-title":"New Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"40470","DOI":"10.1155\/IDOG\/2006\/40470","article-title":"Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract","volume":"2006","author":"Ault","year":"2006","journal-title":"Infect. Dis. Obstet. Gynecol."},{"doi-asserted-by":"crossref","unstructured":"Ge, Y., Zhong, S., Ren, M., Ge, Y., Mao, Y., and Cao, P. (2019). Prevalence of Human Papillomavirus Infection of 65,613 Women in East China. BMC Public Health, 19.","key":"ref_3","DOI":"10.1186\/s12889-019-6487-9"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101649","DOI":"10.1016\/j.canep.2019.101649","article-title":"Risk of Subsequent Malignant Neoplasms after an Index Potentially-HPV-Associated Cancer","volume":"64","author":"Wang","year":"2020","journal-title":"Cancer Epidemiol."},{"doi-asserted-by":"crossref","unstructured":"Kombe, A.J.K., Li, B., Zahid, A., Mengist, H.M., Bounda, G.-A., Zhou, Y., and Jin, T. (2021). Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front. Public Health, 8.","key":"ref_5","DOI":"10.3389\/fpubh.2020.552028"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jiy505","article-title":"Condylomata Acuminata (Anogenital Warts) Contain Accumulations of HIV-1 Target Cells That May Provide Portals for HIV Transmission","volume":"219","author":"Pudney","year":"2019","journal-title":"J. Infect. Dis."},{"doi-asserted-by":"crossref","unstructured":"Smith-McCune, K.K., Shiboski, S., Chirenje, M.Z., Magure, T., Tuveson, J., Ma, Y., Da Costa, M., Moscicki, A.-B., Palefsky, J.M., and Makunike-Mutasa, R. (2010). Type-Specific Cervico-Vaginal Human Papillomavirus Infection Increases Risk of HIV Acquisition Independent of Other Sexually Transmitted Infections. PLoS ONE, 5.","key":"ref_7","DOI":"10.1371\/journal.pone.0010094"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/infdis\/jit035","article-title":"Human Papillomavirus Clearance among Males Is Associated with HIV Acquisition and Increased Dendritic Cell Density in the Foreskin","volume":"207","author":"Tobian","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/14760584.2019.1568876","article-title":"Eradication of Human Papillomavirus and Elimination of HPV-Related Diseases\u2014Scientific Basis for Global Public Health Policies","volume":"18","author":"Lehtinen","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"ref_10","first-page":"e47685","article-title":"A Comprehensive Review of Treatment Approaches for Cutaneous and Genital Warts","volume":"15","author":"Kore","year":"2023","journal-title":"Cureus"},{"doi-asserted-by":"crossref","unstructured":"Dube Mandishora, R.S., Rounge, T.B., Fitzpatrick, M., Christiansen, I.K., Ambur, O.H., Lagstr\u00f6m, S., Stray-Pedersen, B., Tommasino, M., Palefsky, J., and Chirenje, Z.M. (2021). Self-Collected and Clinician-Collected Anal Swabs Show Modest Agreement for HPV Genotyping. PLoS ONE, 16.","key":"ref_11","DOI":"10.1371\/journal.pone.0250426"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/codi.17099","article-title":"Risk of Developing High-Grade Squamous Intraepithelial Lesions or Anal Cancer after Anal Condylomata Treatment in People Living with HIV","volume":"26","author":"Hewitt","year":"2024","journal-title":"Color. Dis."},{"unstructured":"Pennycook, K.B., and McCready, T.A. (2023). Condyloma Acuminata. StatPearls, StatPearls Publishing.","key":"ref_13"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"18099","DOI":"10.1074\/jbc.RA119.010732","article-title":"Reversible Binding of the Anticancer Drug KXO1 (Tirbanibulin) to the Colchicine-Binding Site of \u03b2-Tubulin Explains KXO1\u2019S Low Clinical Toxicity","volume":"294","author":"Niu","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00403-024-03032-x","article-title":"Anti-Tumor Effects of Tirbanibulin in Squamous Cell Carcinoma Cells Are Mediated via Disruption of Tubulin-Polymerization","volume":"316","author":"DeTemple","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00403-024-03205-8","article-title":"Tirbanibulin Decreases Cell Proliferation and Downregulates Protein Expression of Oncogenic Pathways in Human Papillomavirus Containing HeLa Cells","volume":"316","author":"Moore","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"ref_17","first-page":"e784","article-title":"Tirbanibulin 1% Ointment Eradicates HPV-16 (+) Vulvar High-Grade Squamous Intraepithelial Lesion","volume":"36","author":"Moore","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol. (JEADV)"},{"key":"ref_18","first-page":"e468","article-title":"Tirbanibulin 1% Ointment as a Potential Novel Treatment for Anogenital Warts","volume":"36","author":"Braasch","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol. (JEADV)"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdcr.2023.04.011","article-title":"Topical Tirbanibulin Resolves Recalcitrant Condyloma Acuminata: Retrospective Case Series","volume":"37","author":"Moore","year":"2023","journal-title":"JAAD Case Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.23736\/S2784-8671.23.07740-X","article-title":"Anogenital Warts in Two Patients Treated with Topical Tirbanibulin: A New Treatment Option","volume":"159","author":"Agostini","year":"2024","journal-title":"Ital. J. Dermatol. Venereol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and Preliminary Testing of the New Five-Level Version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual. Life Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"114519","DOI":"10.1016\/j.socscimed.2021.114519","article-title":"An EQ-5D-5L Value Set for Italy Using Videoconferencing Interviews and Feasibility of a New Mode of Administration","volume":"292","author":"Finch","year":"2022","journal-title":"Soc. Sci. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.25259\/Cytojournal_24_2021","article-title":"Squamous Intraepithelial Lesions (SIL: LSIL, HSIL, ASCUS, ASC-H, LSIL-H) of Uterine Cervix and Bethesda System","volume":"18","author":"Alrajjal","year":"2021","journal-title":"CytoJournal"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/hiv.13542","article-title":"Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023","volume":"24","author":"Ambrosioni","year":"2023","journal-title":"HIV Med."},{"key":"ref_25","first-page":"e263","article-title":"2012 European Guideline for the Management of Anogenital Warts","volume":"27","author":"Lacey","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e027765","DOI":"10.1136\/bmjopen-2018-027765","article-title":"Effectiveness of Topical and Ablative Therapies in Treatment of Anogenital Warts: A Systematic Review and Network Meta-Analysis","volume":"9","author":"Barton","year":"2019","journal-title":"BMJ Open"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/sextrans-2016-053035","article-title":"Anogenital Warts and Other HPV-Associated Anogenital Lesions in the HIV-Positive Patient: A Systematic Review and Meta-Analysis of the Efficacy and Safety of Interventions Assessed in Controlled Clinical Trials","volume":"93","author":"Werner","year":"2017","journal-title":"Sex. Transm. Infect."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta24470","article-title":"Imiquimod versus Podophyllotoxin, with and without Human Papillomavirus Vaccine, for Anogenital Warts: The HIPvac Factorial RCT","volume":"24","author":"Gilson","year":"2020","journal-title":"Health Technol. Assess."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1177\/0956462418763888","article-title":"Sinecatechins 10% Ointment for Genital Warts: Case Report of a Beneficial Reaction in an HIV-Positive Woman","volume":"29","author":"Bilenchi","year":"2018","journal-title":"Int. J. STD AIDS"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1365-2133.2009.09210.x","article-title":"Imiquimod 5% Cream for External Genital or Perianal Warts in Human Immunodeficiency Virus-Positive Patients Treated with Highly Active Antiretroviral Therapy: An Open-Label, Noncomparative Study","volume":"161","author":"Saiag","year":"2009","journal-title":"Br. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1258\/095646204322637191","article-title":"5% Imiquimod Cream for External Anogenital Warts in HIV-Infected Patients under HAART Therapy","volume":"15","author":"Cusini","year":"2004","journal-title":"Int. J. STD AIDS"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.vaccine.2006.05.031","article-title":"Chapter 6: Epidemiology and Transmission Dynamics of Genital HPV Infection","volume":"24","author":"Burchell","year":"2006","journal-title":"Vaccine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jogc.2020.02.116","article-title":"Stigma as a Barrier to Care for Human Papillomavirus: A Commentary Summarizing Literature and Presenting Recommendations for Health Care Providers","volume":"42","author":"Nagpal","year":"2020","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e02143-19","DOI":"10.1128\/JVI.02143-19","article-title":"Epidermal Growth Factor Receptor and Abl2 Kinase Regulate Distinct Steps of Human Papillomavirus 16 Endocytosis","volume":"94","author":"Bannach","year":"2020","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1743-422X-10-79","article-title":"Activation of Src, Fyn and Yes Non-Receptor Tyrosine Kinases in Keratinocytes Expressing Human Papillomavirus (HPV) Type 16 E7 Oncoprotein","volume":"10","author":"Ferenczi","year":"2013","journal-title":"Virol. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/ijd.17168","article-title":"Efficacy and Tolerability of Tirbanibulin 1% Ointment in the Treatment of Cancerization Field: A Real-Life Italian Multicenter Observational Study of 250 Patients","volume":"63","author":"Nazzaro","year":"2024","journal-title":"Int. J. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jaad.2017.04.012","article-title":"Cryotherapy to Treat Anogenital Warts in Nonimmunocompromised Adults: Systematic Review and Meta-Analysis","volume":"77","author":"Bertolotti","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ijd.17436","article-title":"Topical Tirbanibulin Ointment 1% as a Potential New Treatment for Recalcitrant Plantar Warts: A Case Report","volume":"64","author":"Iacomino","year":"2024","journal-title":"Int. J. Dermatol."}],"container-title":["Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7449\/17\/3\/40\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:21:09Z","timestamp":1760030469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7449\/17\/3\/40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["idr17030040"],"URL":"https:\/\/doi.org\/10.3390\/idr17030040","relation":{},"ISSN":["2036-7449"],"issn-type":[{"type":"electronic","value":"2036-7449"}],"subject":[],"published":{"date-parts":[[2025,4,25]]}}}